CannaKorp is a Massachusetts-based technology start-up that is simplifying and improving the inhalation process for medicinal cannabis patients.
The company has designed and developed a vaporization technology which incorporates a desktop vaporizer device that accepts single-use pods containing precisely prepared ground cannabis.
Under the terms of the agreement, Cann has been granted a license to import and sell the system in Australia and New Zealand.
Cann has also obtained the manufacturing rights, which includes an initial nine-month exclusive right following regulatory approvals.
The vaporizing system will be available as an open platform for licensed medicinal cannabis cultivators looking to have their cannabis available via a vaporization device.
The patent-pending system has a hygienic, one-way valve mouthpiece that is detachable for convenient cleaning.
A microprocessor controls the system to ensure optimal performance including temperature, time and air pressure.
The pod system will allow doctors to prescribe appropriate strains of medicinal cannabis to suit patient requirements.
It is worth noting that Cann has already established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients.
Aurora Cannabis Inc (CVE:ACB), Canada’s second largest listed medicinal cannabis company, is a cornerstone investor in Cann, with a 19.9% shareholding.